Expression of multi drug resistance (MDR1) gene in human promyelocytic leukemia cell line selected with vincristine

Turkish Journal of Cancer

Volumn 35, Issue 2, 2005, Pages 88-92

  Baran, Yusuf ^a   Gündüz, Ufuk ^a   Ural, Ali Uǧur ^b  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

AML; HL60; MDR1; Multidrug resistance; P glycoprotein; RT PCR; Vincristine

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 1; VINCRISTINE;

ACUTE LEUKEMIA; ARTICLE; CELL STRAIN HL 60; CELL SURVIVAL; CELL VIABILITY; CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IC 50; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PROMYELOCYTIC LEUKEMIA; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

EID: 28244444857     PISSN: 10193103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Zijlstra JG, de Vries EGE, Mulder NH. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res 1987;47:1780-4.
2. Greenberger LM, Williams SS, Distinct P-glycoprotein precursors are overproduced in independently isolated drug-resistant cell lines. Proc Am Assoc Cancer Research 1988;85:3762-6.
3. Endicott JA, Ling V. The biochemistry of P-glycoprotein mediated multidrug resistance. Annu Rev Biochem 1989;58-137-71.
4. Marie JP, Zittoun R. Multidrug resistance (mdr1) gene expression in adult leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 1992;79:473.
5. Tsurao T. Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics. Cancer Treatment Reports 1983;67:889.
6. Nielsen D, Torben S. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines. Biochimica et Biophysica Acta 1992;1139:169-83.
7. Skovsgaard T. Mechanism of cross-resistance between Vincristine and daunorabicin in Ehrlich ascites tumor cells. Cancer Res 1978;38:4722-7.
8. Ogretmen B, Bahadori H, McCauley M, et al. Lack of correlation of MRP and gamma-glutamylcysteine synthetase overexpression with doxorubicin resistance due to increased apoptosis in SV40 large T-antigen-transformed human mesothelial cells. Cancer Chemother Pharmacol 1998;42:441-6.
9. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd Edition, New York: Cold Spring Harbor, Section E5, 1989.
10. Ogretmen B, Ratajczak H, Kats A, et al. Effects of staining of RNA with ethidium bromide before electrophoresis on performance of northern blots. Biotechniques 1993;14:932-5.
11. Chen CJ, Chin JE, Ueda K. Internal duplication and homology with bacterial transport proteins in the MDR1 gene from multidrug resistant human cells. Cell 1986;47:381-9.
12. Jendiroba DB, Klostergaard J, Keyhani A, et al. Effective cytotoxicity against human leukemias and chemotherapy-resistant leukemia cell lines by N-N-dimethylsphingosine. Leuk Res 2002;26:301-10.
13. Masao Hirose, Yasuhiro Kuroda. P53 may mediate the mdr1 expression via the WT1 gene in human Vincristine-resistant leukemia/lymphoma cell lines. Cancer Letters 1998;129:165-71.
14. McGrath T, Latoud C, Arnold ST, et al. Analysis of resistance associated membrane proteins and levels of mdr gene expression. Biochemical Pharmacology 1989;38:3611-9.